The most frequent treatment-related adverse events reported were headache, myalgia (muscle pain), dyspepsia (stomach upset following meals) and back pain. These events were dose-related, generally mild-to-moderate, and tended to abate with continued treatment. A global Phase III investigational clinical program for Cialis is currently underway.